Use of biosimilars and generics had a profound effect on the savings targets of NHS with NHS saving over £300m in 2017-18. The original savings target for NHS trusts was set at £250m.
Read more at https://www.pharmaceutical-journal.com//news-and-analysis/news/switching-to-biosimilar-and-generic-medicines-saved-the-nhs-over-300m-in-a-year/20205275.fullarticle?firstPass=false#cxrecs_s
